Nucleolin overexpression in human PDAC tumors is a negative prognostic factor for patients, and nucleolin inhibition by N6L inhibits PDAC growth and metastasis in tumor-bearing mice [2]. The gene discussed is NUCLEOLIN; the disease is neoplasm.